Adeia Inc. develops and licenses intellectual property for the semiconductor and media industries. Its media portfolio supports technologies used in digital entertainment, pay-TV, streaming, advertising, e-commerce and personalized interactive experiences, while its semiconductor portfolio includes hybrid bonding, advanced packaging and semiconductor processing technologies for 3D integration and high-performance computing.
Company updates commonly cover multi-year IP license agreements and renewals, patent enforcement and litigation resolutions, quarterly financial results, cash generation, debt reduction, dividends, share repurchases, credit ratings and governance matters. Announcements also track customer relationships across media platforms, consumer electronics, semiconductor foundries, high-performance computing, commerce and connected-device markets.
Adeia (Nasdaq: ADEA) said the Federal Court of Canada issued a favorable judgment on Oct 24, 2025, finding that Videotron’s Helix, illico+ and illico video platforms infringe an Adeia media patent.
The court also found Helix infringed an additional Adeia patent and awarded Adeia damages for both upheld patents, while ruling two other asserted patents invalid. A permanent injunction was granted. A public redacted ruling is expected shortly and the parties have until late November 2025 to file a notice of appeal.
Adeia (Nasdaq: ADEA) will release third quarter 2025 financial results for the period ended September 30, 2025 on Monday, November 3, 2025.
The company will host an earnings conference call on the same day at 2:00 p.m. PT / 5:00 p.m. ET. U.S. dial-in is +1 (888) 660-6411; international dial-in is +1 (929) 203-0849. Participants are asked to dial in 15 minutes early.
A live webcast will be available at the Q3 2025 Earnings Call Webcast, with a webcast replay accessible through November 3, 2026. A telephonic replay is available through November 10, 2025 at +1 (609) 800-9909 (playback ID# 6089024).
Adeia (Nasdaq: ADEA) has entered into a long-term intellectual property (IP) license agreement with Altice USA's Optimum, one of the largest broadband and video service providers in the United States. The agreement covers Optimum's internet services, cable television, and OTT streaming platforms.
The deal resolves all outstanding litigation between the companies and enables Optimum to utilize Adeia's patented innovations in content discovery, search, and personalization technologies. Through this partnership, Optimum can offer advanced features such as content recommendations and voice search capabilities to enhance their customers' entertainment experience.
Niagen Bioscience (NASDAQ: NAGE) has published groundbreaking clinical study results in Aging Cell, demonstrating the efficacy of their patented nicotinamide riboside (NR) ingredient, Niagen®, in treating Werner syndrome (WS), a rare genetic aging disorder. The 52-week randomized, double-blind, placebo-controlled crossover trial showed that daily 1,000mg Niagen supplementation increased NAD+ levels by approximately 140% and improved cardiovascular and skin health markers.
Key findings include improved arterial stiffness, beneficial changes in HDL particles, and reduced skin ulcer size. The study involved nine individuals with WS, with no moderate or severe adverse events reported. This research expands Niagen's rare disease portfolio, which includes promising results in Ataxia Telangiectasia (AT), where the FDA has granted both Orphan Drug Designation and Rare Pediatric Disease Designation.
Adeia (Nasdaq: ADEA) reported Q2 2025 financial results with revenue of $85.7 million, slightly down from $87.7 million in Q1. The company achieved GAAP net income of $16.7 million with diluted EPS of $0.15 and non-GAAP diluted EPS of $0.25.
Key highlights include signing 5 new deals across semiconductors, e-commerce, and OTT streaming, including agreements with ST Microelectronics and Warby Parker. Adeia also introduced RapidCool, a new direct-to-chip liquid cooling technology for high-performance semiconductors.
The company maintained its full-year 2025 revenue guidance of $390-430 million while lowering operating expense projections. During Q2, Adeia paid down $11.1 million on its term loan and declared a quarterly dividend of $0.05 per share.
Adeia (Nasdaq: ADEA) has scheduled its second quarter 2025 financial results announcement for August 5, 2025, after market close. The company will host an earnings conference call at 2:00 PM PT (5:00 PM ET) on the same day.
Investors can access the call via phone (U.S.: +1 (888) 660-6411; International: +1 (929) 203-0849) or through the webcast link. A replay will be available through August 4, 2026 via webcast, and a telephonic replay through August 12, 2025 using playback ID# 6089024.
Adeia Inc (Nasdaq: ADEA) has scheduled the release of its first quarter 2025 financial results on Monday, May 5, 2025, after market close. The company will host an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day.
Participants can join via phone by dialing +1 (888) 660-6411 (U.S.) or +1 (929) 203-0849 (International). A webcast replay will be available through May 4, 2026, and a telephonic replay will be accessible until May 12, 2025, by dialing +1 (609) 800-9909 with playback ID# 6089024.
Adeia (Nasdaq: ADEA) has nominated Sandeep Vij to its Board of Directors for election at the 2025 Annual Meeting of Shareholders. Vij, co-founder and managing partner of Argean Capital, brings over 25 years of experience in semiconductor design, IP licensing, and technology investing.
Vij's background includes serving as CEO of MIPS Technologies and leadership roles at Cavium Networks, Xilinx, and Altera He currently serves on the board of Coherent Corp. and holds engineering degrees from San Jose State University and Stanford University.
The nomination coincides with the retirement of Raghavendra Rau, who has served on Adeia's board since 2020 and chaired the nominating and corporate governance committee. Rau played a important role during the company's separation from its product business in 2022.